Cargando…
The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma
Autores principales: | Elsabah, Hesham, Aldapt, Mahmood B., Taha, Ruba, Soliman, Dina S., Elomri, Halima, Ibrahim, Feryal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università Cattolica del Sacro Cuore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643781/ https://www.ncbi.nlm.nih.gov/pubmed/33194156 http://dx.doi.org/10.4084/MJHID.2020.082 |
Ejemplares similares
-
Plasma Cell Myeloma with an Aggressive Clinical Course and Anaplastic Morphology in a 22-Year-Old Patient: A Case Report and Review of Literature
por: Elsabah, Hesham, et al.
Publicado: (2020) -
Prediction of Multiple Clinical Complications in Cancer Patients to Ensure Hospital Preparedness and Improved Cancer Care
por: Padmanabhan, Regina, et al.
Publicado: (2022) -
A Rare Case of Hairy Cell Leukemia with Unusual Loss of CD123 Associated with COVID-19 at the Time of Presentation
por: Kohla, Samah, et al.
Publicado: (2020) -
PB1997: DARATUMUMAB, LENALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE FOR TRANSPLANT-ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA: OUTCOME AND SAFETY PROFILE FROM A REAL-WORLD SINGLE CENTER EXPERIENCE
por: Elsabah, H., et al.
Publicado: (2022) -
Acute Myeloid Leukemia in Qatar (2010–2016): Clinical, Biological, and Prognostic Factors and Treatment Outcomes
por: El Omri, Halima, et al.
Publicado: (2020)